This guide offers an educational, technical overview of ent & soft tissue ablation and the device technologies used in this field. The choice between medical therapy, phototherapy, and ablative options is individualized and should be determined by a qualified clinician after appropriate assessment. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Allergic Rhinitis and ENT Soft Tissue Conditions
Conventional management often centres on avoidance measures and pharmacological options such as antihistamines and intranasal corticosteroid sprays, though not every patient tolerates or responds fully to medication. Separately, ENT soft tissue conditions such as inferior turbinate hypertrophy contributing to nasal obstruction may be addressed with radiofrequency turbinate reduction, and other lesions with soft tissue ablation techniques. Intranasal phototherapy has emerged in the literature as a drug-free approach that is intended to modulate the local allergic response using controlled light energy delivered inside the nasal cavity.
Core Technologies and Options
Intranasal Phototherapy. Intranasal phototherapy is a drug-free technique that delivers controlled light energy directly to the nasal mucosa through a nasal applicator. It is intended to act locally on the inflamed lining rather than to introduce any systemic medication into the body. Rhinophototherapy (Combined Wavelengths). Rhinophototherapy describes phototherapy applied within the nose, and in the literature it commonly combines more than one part of the light spectrum. The INVAMED Voltran system is described as delivering a combination of narrow-band UVB, visible light, and infrared through intranasal delivery. Narrow-Band UVB in Nasal Phototherapy. Narrow-band UVB refers to a specific band of ultraviolet light that has been studied for its effects on inflammatory and immune responses in tissue. Within the INVAMED Voltran system it forms one component of the combined narrow-band UVB, visible light, and infrared output. Drug-Free Allergic Rhinitis Approach. A drug-free approach to allergic rhinitis aims to influence symptoms without relying on daily antihistamine tablets or corticosteroid sprays. Intranasal phototherapy is positioned in this category because it uses light energy rather than a pharmacological agent. Radiofrequency Turbinate Reduction. Radiofrequency turbinate reduction is a soft tissue technique that uses radiofrequency energy to shrink enlarged inferior turbinate tissue contributing to nasal obstruction. By reducing turbinate volume, the approach is intended to improve the nasal airway in appropriately selected patients. ENT Soft Tissue Ablation. Soft tissue ablation in ENT uses focused energy to remove or reduce targeted tissue with the aim of precise treatment and controlled bleeding. According to the site's educational FAQ, ENT laser surgery has been applied to snoring via laser palatoplasty, turbinate hypertrophy, tonsil reduction, vocal cord lesions, and nasal polyps.
Comparing the Approaches
Intranasal phototherapy vs Intranasal steroid spray. Intranasal phototherapy uses light energy delivered inside the nose, whereas an intranasal steroid spray delivers a corticosteroid medication to the mucosa. Both approaches target the nasal lining, but they differ in mechanism, and comparative evidence is discussed in the clinical literature. Intranasal phototherapy vs Antihistamines. Antihistamines act pharmacologically to blunt the histamine-driven components of allergic rhinitis and are usually taken orally. Some patients seek a drug-free option because of medication tolerability, while others prefer the convenience of tablets. Radiofrequency turbinate reduction vs Turbinate surgery. Radiofrequency turbinate reduction uses energy to shrink turbinate tissue in a minimally invasive fashion, often as an office-based option. The radiofrequency route is generally positioned as less invasive, though the appropriate technique depends on the degree of hypertrophy.
INVAMED Portfolio in This Area
INVAMED's related devices include: Voltran Phototherapy System for Allergic Rhinitis. Detailed specifications for each are provided in the product documentation.
Key Considerations
- Any device that includes ultraviolet output is used strictly according to its instructions for use and under clinician supervision.
- Intranasal phototherapy is drug-free by design, which some clinicians may weigh for patients seeking to avoid daily medication.
- Session parameters cited by INVAMED, such as the approximately five-minute Voltran session, describe the manufacturer's stated design rather than a guaranteed outcome.
Frequently Asked Questions
Who decides which ENT treatment is appropriate?
Only a qualified ENT clinician can decide, based on individual assessment of allergy and nasal anatomy; this article is educational and not a treatment recommendation.
Does phototherapy replace allergy medication?
Phototherapy is a drug-free alternative studied for allergic rhinitis, but whether it complements or is used instead of medication is a clinical decision, not something this content can advise.
What wavelengths does the Voltran system use?
According to INVAMED, the Voltran system combines narrow-band UVB, visible light, and infrared for intranasal delivery; exact parameters are given in the product documentation.
About INVAMED
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Important Disclaimer
The information here is provided for educational purposes and to describe device technology; it is not a substitute for professional medical advice, diagnosis, or treatment. Only a licensed healthcare provider can determine whether a given procedure or device is appropriate for a specific patient. INVAMED products are restricted to use by qualified professionals following the official IFU. Regulatory clearance and labeling differ between regions, and not all products or indications are available in every market.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.